Product Information
TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) is a generic product labeled by Accord Healthcare Inc., priced at $0.1613 per EA under NDC 16729004201. Its NADAC has been published 633 times since Nov 28, 2013.
FDA first approved this application on Aug 31, 2011. Its Orange Book therapeutic-equivalence code is BX.
Strength
1 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729004201
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
TACROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA091195FDA Approved
8/31/2011
TE Code
BX
On Market Since
9/30/2011
Pharmacological Classes
Price Statistics
The NADAC for TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) has been published 633 times since Nov 28, 2013, and over the history we have for it it has declined 89.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1613 per EA |
|---|---|
| All-time high | $1.6306 (Feb 12, 2014) |
| All-time low | $0.1572 (Nov 20, 2024) |
| 52-week high | $0.1729 |
| 52-week low | $0.1613 |
| Median price | $0.3051 |
| Average price | $0.4675 |
| Largest weekly change | +114.2% (Oct 23, 2019) |
| Weeks tracked | 633 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
0.0%
6M
-2.1%
1Y
-6.7%
3Y
-30.0%
5Y
-64.8%
All
-89.1%
Last surveyed May 27, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE)?
The current National Average Drug Acquisition Cost (NADAC) for TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE), manufactured by Accord Healthcare Inc., is $0.1613 per EA (NDC 16729004201), effective May 27, 2026.
How has the price of TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) changed over time?
Over the history we have for it, the NADAC for TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) has declined 89.1%. It has been tracked across 633 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE)?
Since Nov 28, 2013, the NADAC for TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) has ranged from a low of $0.1572 (Nov 20, 2024) to a high of $1.6306 (Feb 12, 2014), with a median of $0.3051 per EA.
Are there cheaper alternatives to TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE)?
Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE), is $0.1518 per EA — about 6% below TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE).
Who manufactures TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE)?
TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) (NDC 16729004201) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.